Concanavalin A dependent cell-mediated cytotoxicity (CDCMC) in bronchoalveolar lavage (BAL) fluid of patients with interstitial lung diseases (ILD). Evidence of cytolytic T-lymphocyte (CTL) activity.
D000542:Alveolitis, Extrinsic Allergic / Q000276:immunology / Q000473:pathology; D001826:Body Fluids / Q000276:immunology* / Q000473:pathology; D001980:Bronchi / Q000276:immunology* / Q000473:pathology; D003208:Concanavalin A / Q000494:pharmacology*; D003602:Cytotoxicity, Immunologic; D006801:Humans; D008213:Lymphocyte Activation / Q000187:drug effects; D011650:Pulmonary Alveoli / Q000276:immunology* / Q000473:pathology; D011658:Pulmonary Fibrosis / Q000276:immunology* / Q000473:pathology; D012507:Sarcoidosis / Q000276:immunology / Q000473:pathology; D007507:Therapeutic Irrigation
D003208:Concanavalin A